指南与共识消化与肝胆胰病理

胃食管癌肿瘤浸润淋巴细胞形态学评估建议

Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma: A report on behalf of the International Immuno-Oncology Biomarker Working Group.
指南 / 共识 · Histopathology · 2026-02-05

本文为国际免疫肿瘤生物标志物工作组(International Immuno-Oncology Biomarker Working Group)发布的指南,针对胃食管癌(GEC)中肿瘤浸润淋巴细胞(TILs)的形态学评估提出标准化建议。鉴于乳腺癌中TILs评估已标准化而GEC尚缺乏综合指南,本文通过叙述性综述现有文献,提出GEC中TILs标准化评估与报告的框架,并强调GEC病理特有陷阱。

要点

  • 推荐在GEC中采用标准化框架评估H&E染色切片上的TILs。
  • TILs评估需注意GEC病理特有的陷阱。
  • 该建议为TILs作为生物标志物的广泛使用和验证迈出关键第一步。

核心结论

  • 提出了胃食管癌中TILs标准化评估与报告的推荐框架。

研究设计与样本

  • 国际免疫肿瘤生物标志物工作组发布的叙述性综述与建议报告。

主要发现

  • TILs可通过标准H&E染色切片评估,是广泛可及且成本效益高的生物标志物。
  • TILs可提供免疫系统与肿瘤细胞相互作用的预后信息。
  • 乳腺癌中TILs形态学评估已标准化,但GEC仍缺乏综合指南。

关键数值与推荐

  • 建议对GEC中TILs进行标准化评估和报告,并注意GEC病理特有陷阱。

临床怎么用

  • 病理科医生可参照本建议在GEC H&E切片中标准化评估TILs。

局限性

  • 本文为叙述性综述,建议基于现有文献提出,尚需广泛验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In the era of immune checkpoint inhibitors for cancers, the need for prognostic biomarkers to identify patients most likely to achieve a durable response has become increasingly more relevant. Tumour-infiltrating lymphocytes (TILs) have gained significant interest, as they can be evaluated using standard haematoxylin and eosin-stained slides, making it a widely accessible and cost-effective biomarker. In addition to their practicality, TILs provide prognostic insights into the interplay between the immune system and tumour cells. While the morphological assessment of TILs has been standardised in breast cancer, comprehensive guidelines for their evaluation in gastro-oesophageal carcinomas (GEC) are still lacking. This narrative review examines the current literature on the composition, clinical implications and therapeutic utility of TILs in GEC. These insights are used to propose a framework with recommendations for standardised evaluation and reporting of TILs in GEC, while also highlighting pitfalls specific to GEC pathology. These recommendations serve as a vital first step towards the widespread use and validation of TILs as a biomarker.

来源:Histopathology,查看原文。版权归原作者所有。

引用

  1. Weeda YA, Salgado R, van Herpe F, et al. Making sense of TILs: recommendations for morphological assessment of tumour-infiltrating lymphocytes in gastro-oesophageal carcinoma: A report on behalf of the International Immuno-Oncology Biomarker Working Group. Histopathology. 2026. PMID: 41640295. doi:10.1111/his.70089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。